Results 211 to 220 of about 900,860 (290)
A Contemporary Pathomechanistic Nosology of Inherited Lysosomal Disorders. [PDF]
McCarron EP +7 more
europepmc +1 more source
ABSTRACT Background Interest in dietary supplements targeting both skin and biological aging biomarkers is rapidly growing, yet existing studies lack rigorous clinical validation of combined oral–topical regimens and concurrent assessment of skin and systemic biomarkers.
Jie‐Hua Chen +14 more
wiley +1 more source
α-Mangostin attenuates <i>Pseudomonas aeruginosa</i> virulence by targeting PqsR and inhibiting PQS-mediated quorum sensing. [PDF]
Liu D +12 more
europepmc +1 more source
GmERF109 is strongly induced in P. sojae‐resistant but not susceptible soybeans. GmERF109 functions as a nuclear AP2/ERF transcription factor, P. sojae directly binding the GCC‐box to activate GmG4DT‐like expression. The GmERF109–GmG4DT‐like module enhances glyceollin I accumulation for soybean resistance to P. sojae.
Xin Fang +19 more
wiley +1 more source
Impact of migalastat therapy on corneal deposits in a female with Fabry disease: A case report. [PDF]
Vitturi N +5 more
europepmc +1 more source
Mechanism of action of alpha-galactosidase.
C D, Mathew, K, Balasubramaniam
openaire +1 more source
Magnesium (Mg2+) attenuates renal injury in ischemia–reperfusion and radiation‐induced kidney injury models in association with reduced DNA damage response markers, cellular senescence, inflammation, and fibrosis. Mg2+ treatment is associated with reduced H3K4me3 enrichment at the p16INK4a promoter, attenuation of senescence‐associated pathways, and ...
Makoto Matsubara +12 more
wiley +1 more source
A novel pyridine–thiazole derivative, Compound 8, exhibited potent dual antitrypanosomatid activity. It demonstrated remarkable in vitro efficacy against Trypanosoma cruzi (IC50 = 1.0 µM) and L. amazonensis (IC50 = 3.9 µM). Molecular docking studies suggested interactions with heme and multiple molecular targets.
Anderson José Firmino Santos da Silva +10 more
wiley +1 more source
Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. [PDF]
Elsaid H +4 more
europepmc +1 more source
Pioglitazone is an antidiabetic drug acting as a peroxisome proliferator‐activated receptor γ (PPARγ) agonist and later repositioned as a monoamine oxidase B (MAO‐B) inhibitor. Despite promising preclinical premises, it showed a lack of efficacy in clinical trials as a treatment for neurodegenerative diseases.
Filippo Basagni +12 more
wiley +1 more source

